Your browser doesn't support javascript.
loading
Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.
Xing, Peipei; Zhang, Jin; Yan, Zhao; Zhao, Gang; Li, Xubin; Wang, Guowen; Yang, Yun; Zhao, Jun; Xing, Ruwei; Teng, Sheng; Ma, Yulin; Liao, Zhichao; Ren, Zhiwu; Zhang, Chao; Han, Xiuxin; Zhang, Wei; Chen, Kexin; Wang, Ping; Yang, Jilong.
Afiliación
  • Xing P; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Zhang J; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Yan Z; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Zhao G; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Li X; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Wang G; Pharmacological Research Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Yang Y; Department of Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Zhao J; Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Xing R; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Teng S; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Ma Y; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Liao Z; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Ren Z; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Zhang C; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Han X; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Zhang W; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Chen K; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Wang P; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
  • Yang J; Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, People's Republic of China.
Oncotarget ; 8(22): 36716-36727, 2017 May 30.
Article en En | MEDLINE | ID: mdl-27888623
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Osteosarcoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Osteosarcoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos